In Vivo Ablation of NF-κB Cascade Effectors Alleviates Disease Burden in Myeloproliferative Neoplasms

Investigators systematically ablated NF-κB signaling effectors to identify core dependencies using a series of primary samples and syngeneic and patient–derived xenograft mouse models.